• Affiliate Professor, Global Health
  • Affiliate Professor, Epidemiology
Ann Duerr

Fred Hutchinson Cancer Research Center
HIV Vaccine Trials Network
Box 358080 (LE 500)
Seattle, WA 98109
United States

Phone Number: 
206-667-7938
Fax: 
206-667-7711
Select from the following:
Biography 

Ann Duerr's research focuses on AIDS and HIV prevention, including novel vaccine strategies for induction of mucosal immunity, studies on antiretroviral therapy (ART), clinical trials in resource-poor settings and eludicating factors that help prevent sexual transmission of HIV. She has published widely on HIV infection in women, biological and epidemiological determinants of HIV transmission, and HIV-STD interactions. She has served on numerous advisory committees, both domestically and internationally, and worked extensively with the World Health Organization as a consultant.

Education 
  • BSc (McGill University (Canada))
  • PhD (Massachusetts Institute of Technology)
  • MD (Harvard University)
  • MPH (Johns Hopkins University)
Country Affiliations 
Languages 
  • French
Health Topics 
  • Cervical Cancer
  • Cost-Effectiveness
  • Drug and Vaccine Development
  • Epidemiology
  • HIV Transmission
  • HIV/AIDS
  • HPV
  • Prevention
  • Tobacco, Alcohol, and Drug Use
  • Transgender Health
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Expertise 

HIV, Vaccines, Women's Health, HPV, STDs

Publications 

Paramsothy P, Jamieson DJ, Heilig CM, Schuman PC, Klein RS, Shah KV, Rompalo AM, Cu-Uvin S, Duerr A. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol 2009; 113:26-31


Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert P, Loufty M, Mehrotra D, Duerr A; for the Step Study Protocol Team. An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). J Infect Dis 203:765-772, 2011 [PMCID: PMC3119328].

Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, Del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; for Step/HVTN 504 Study Team. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis 206:258-266, 2012 [PMCID: PMC3490694].

Lama JR, Brezak A, Dobbins JG, Sanchez H, Cabello R, Rios J, Bain C, Ulrich A, De la Grecca R, Sanchez J, Duerr A.
Design Strategy of the Sabes Study: Diagnosis and Treatment of Early HIV Infection Among Men Who Have Sex With Men and Transgender Women in Lima, Peru, 2013-2017. Am J Epidemiol. 2018

Long J, Ulrich A, White E, Dasgupta S, Cabello R, Sanchez H, Lama J, Duerr A. Characterizing men who have sex with transgender women in Lima, Peru: Sexual behavior and partnership profiles. AIDS and Behavior, 2019 Jul 12. doi: 10.1007/s10461-019-02590-w.

Dimitrov D, Wood D, Ulrich A, Swan DA, Adamson B, Lama JR, Sanchez J, Duerr A. Projected effectiveness of HIV detection during early infection and rapid ART initiation among MSM and transgender women in Peru: A modeling study. Infect Dis Model. 2019 Apr 6;4:73-82. doi: 10.1016/j.idm.2019.04.001.